Abstract
Puerarin is a major active ingredient extracted from the traditional Chinese medicine Ge-gen. The purpose of this study is to investigate the protective effect of puerarin on diabetic retinopathy (DR) and its mechanisms in rats. Seventy-two male Wistar rats were selected and divided at random into three main groups: control group, streptozotocin (STZ) group and puerarin + STZ group. Retinal histopathological observation and electron microscopic examination were performed; retinal vascular endothelial growth factor (VEGF) and hypoxia inducible factor 1 (HIF-1α) gene expressions were examined by Reverse transcription-polymerase chain reaction (RT-PCR) analysis. Results showed that the DR induced by STZ was significantly reduced by the treatment of puerarin as judged by the reduction of morphological changes of inner nuclear layer and outer nuclear layer at any time-point. Puerarin regulates expressions of VEGF and HIF-1α stimulated by STZ. It was concluded that puerarin exerts significant protective effects against DR in rats, likely regulating angiogenesis factors expressions, and thus may be an effective and promising medicine for treatment of DR.
Similar content being viewed by others
References
Sato S, Yamamoto T, Yamashita H (2006) Diabetic retinopathy-state of arts of diagnosis and treatment. Nippon Rinsho Suppl 3:161–168
Moss SE, Klein R, Klein BE (1998) The 14-year incidence of visual loss in a diabetic population. Ophthalmology 105:998–1003. doi:10.1016/S0161-6420(98)96025-0
Tolentino MJ, Miller JW, Gragoudas ES, Jakobiec FA, Flynn E, Chatzistefanou K et al (1996) Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 103:1820–1828
Cherdshewasart W, Subtang S, Dahlan W (2007) Major isoflavonoid contents of the phytoestrogen rich-herb Pueraria mirifica in comparison with Pueraria lobata. J Pharm Biomed Anal 43:428–434. doi:10.1016/j.jpba.2006.07.013
Kirakosyan A, Kaufman PB, Warber S, Bolling S, Chang S, Duke JA (2003) Quantification of major isoflavonoids and l-canavanine in several organs of Kudzu vine (Pueraria lobata) and in starch samples derived from Kudzu roots. Plant Sci 164:883–888. doi:10.1016/S0168-9452(03)00077-3
Xiong FL, Sun XH, Gan L, Yang XL, Xu HB (2006) Puerarin protects rat pancreatic islets from damage by hydrogen peroxide. Eur J Pharmacol 529:1–7. doi:10.1016/j.ejphar.2005.10.024
Lu XR, Gao E, Xu LZ, Li HZ, Kang B, Chen WN et al (1986) Blocking effect of puerarin on beta-adrenoceptors of isolated organs and the whole animal. Acta Pharmacol Sin 7:537–539
Cherdshewasart W, Sutjit W (2007) Correlation of antioxidant activity of major isoflavonoid contents of the phytoestrogen-rich Pueraria mirifica and Pueraria lobata. Phytomedicine 15:38–43. doi:10.1016/j.phymed.2007.07.058
Guerra MC, Speroni E, Broccoli M, Cangini M, Pasini P, Minghett A et al (2000) Comparison between Chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin antioxidant properties and effect on rat liver CYP-catalyzed drug metabolism. Life Sci 67:2997–3006. doi:10.1016/S0024-3205(00)00885-7
Benlhabib E, Baker JI, Keyler DE, Singh AK (2004) Effects of purified puerarin on voluntary alcohol intake and alcohol withdrawal symptoms in P rats receiving free access to water and alcohol. J Med Food 7:180–186. doi:10.1089/1096620041224102
Lin RC, Guthrie S, Xie CY, Mai K, Lee DY, Lumeng L et al (1996) Isoflavonoid compounds extracts from Pueraria lobata suppress alcohol preference in a pharmacogenetic rat model of alcoholism. Alcohol Clin Exp Res 20:659–663. doi:10.1111/j.1530-0277.1996.tb01668.x
Keung WM, Vallee BL (1998) Kudzu root: an ancient Chinese source of modern antidipsotropic agents. Phytochemistry 47:499–506. doi:10.1016/S0031-9422(97)00723-1
Chueh FS, Chang CP, Chio CC, Lin MT (2004) Puerarin acts through brain serotonergic mechanisms to induce thermal effects. J Pharmacol Sci 96:420–427. doi:10.1254/jphs.FP0040424
Xuan B, Zhou YH, Yang RL, Li N, Min ZD, Chiou GC (1999) Improvement of ocular blood flow and retinal functions with puerarin analogs. J Ocul Pharmacol Ther 15:207–216
Adamis AP, Miller JW, Bernal MT, D’Amico DJ, Folkman J, Yeo TK et al (1994) Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445–450
Dieudonné SC, La Heij EC, Diederen RM, Kessels AG, Liem AT, Kijlstra A et al (2007) Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy. Ophthalmic Res 39:148–154. doi:10.1159/000103234
Zhang S, Chen S, Shen Y, Yang D, Liu X, Sun-chi AC et al (2006) Puerarin induces angiogenesis in myocardium of rat with myocardial infarction. Biol Pharm Bull 29:945–950. doi:10.1248/bpb.29.945
Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD et al (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 9:4604–4613
Levy NS, Goldberg MA, Levy AP (1997) Sequencing of the human vascular endothelial growth factor (VEGF) 3′ untranslated region (UTR): conservation of five hypoxia-inducible RNA-protein binding sites. Biochim Biophys Acta 1352:167–173
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Teng, Y., Cui, H., Yang, M. et al. Protective effect of puerarin on diabetic retinopathy in rats. Mol Biol Rep 36, 1129–1133 (2009). https://doi.org/10.1007/s11033-008-9288-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-008-9288-2